AAAAAA
Results:
1-11
|
Results: 11
Authors:
Zier, K
Maddux, JM
Johnson, K
Sung, M
Mandeli, J
Eisenbach, L
Schwartz, M
Citation: K. Zier et al., Surrogate markers of antitumor responses: In vitro activation of T cells by autologous tumor peptides, CLIN CANC R, 7(3), 2001, pp. 818S-821S
Authors:
Tirosh, B
Fridkin, M
Tzehoval, E
Vadai, E
Lemonnier, FA
Eisenbach, L
Citation: B. Tirosh et al., Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing, J IMMUNOTH, 23(6), 2000, pp. 622-630
Authors:
Carmon, L
Tzehoval, E
Tirosh, B
el-Shami, KM
Bar-Haim, E
Vadai, E
Feldman, M
Eisenbach, L
Citation: L. Carmon et al., Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles, J IMMUNOTH, 23(3), 2000, pp. 344-352
Authors:
Eisenbach, L
Bar-Haim, E
El-Shami, K
Citation: L. Eisenbach et al., Antitumor vaccination using peptide based vaccines, IMMUNOL LET, 74(1), 2000, pp. 27-34
Authors:
Zier, K
Johnson, K
Maddux, JM
Sung, M
Mandeli, J
Eisenbach, L
Schwartz, M
Citation: K. Zier et al., IFN gamma secretion following stimulation with total tumor peptides from autologous human tumors, J IMMUNOL M, 241(1-2), 2000, pp. 61-68
Authors:
Carmon, L
El-Shami, KM
Paz, A
Pascolo, S
Tzehoval, E
Tirosh, B
Koren, R
Feldman, M
Fridkin, M
Lemonnier, FA
Eisenbach, L
Citation: L. Carmon et al., Novel breast-tumor-associated MUC1-derived peptides: Characterization in Db-/- x beta 2 microglobulin (beta 2m) null mice transgenic for a chimeric HLA-A2.1/D-b-beta 2 microglobulin single chain, INT J CANC, 85(3), 2000, pp. 391-397
Authors:
El-Shami, KM
Tirosh, B
Popovic, D
Carmon, L
Tzehoval, E
Vadai, E
Feldman, M
Eisenbach, L
Citation: Km. El-shami et al., Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide, INT J CANC, 85(2), 2000, pp. 236-242
Authors:
El-Shami, KM
Tzehoval, E
Vadai, E
Feldman, M
Eisenbach, L
Citation: Km. El-shami et al., Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines, J INTERF CY, 19(12), 1999, pp. 1391-1401
Authors:
Tirosh, B
el-Shami, K
Vaisman, N
Carmon, L
Bar-Haim, E
Vadai, E
Feldman, M
Fridkin, M
Eisenbach, L
Citation: B. Tirosh et al., Immunogenicity of H-2K(b)-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination, IMMUNOL LET, 70(1), 1999, pp. 21-28
Authors:
el-Shamil, K
Tirosh, B
Bar-Haim, E
Carmon, L
Vadai, E
Fridkin, M
Feldman, M
Eisenbach, L
Citation: K. El-shamil et al., MHC class I-restricted epitope spreading in the context of tumor rejectionfollowing vaccination with a single immunodominant CTL epitope, EUR J IMMUN, 29(10), 1999, pp. 3295-3301
Authors:
Popovic, D
El-Shami, KM
Vadai, E
Feldman, M
Tzehoval, E
Eisenbach, L
Citation: D. Popovic et al., Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine Interleukin 12, CLIN EXP M, 16(7), 1998, pp. 623-632
Risultati:
1-11
|